PDF
ePub
Citation
Print
Abstract
Systemic lupus erythematosus(SLE) is autoimmune disease in which involves systemic organs. Hematological manifestations are common in patients with SLE but aplastic anemia is very rare and, although various immunosuppressants have been tried, there is no established treatment in aplastic anemia associated with SLE. Furthermore, disease course and prognosis may be different from other aplastic anemia. A 42-year-old woman presented with fever, chilling, myalgia, general weakness, pancytopenia. Her bone marrow aspirate and biopsy revealed almost acellular bone marrow with rare foci of hematopoietic elements and she was diagnosed with SLE simultaneously. High-dose methyprednisolone, prednisolone and cyclophosphamide therapies had been unsuccessful in controlling pancytopenia. Cyclosproine was started and the aplastic anemia was responded. Now she was free of transfusion with more than 10 g/dL of hemoglobin.
REFERENCES
1). Brodsky RA., Jones RJ. Aplastic anaemia. Lancet. 2005. 365:1647–56.
2). Robak T., Robak E., Sysa-Jedrzej owska A. Hematologic problems in systemic lupus erythematosus. Acta Haematol Pol. 1995. 26:145–51.
3). Garcia Tello A., Villegas Martinez A., Gonzalez Fernandez AF. Hematological abnormalities in patients with systemic lupus erythematosus. An Med Interna. 2002. 19:539–43.
4). Keeling DM., Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993. 7:199–207.
5). Roffe C., Cahill MR., Samanta A., Bricknell S., Durrant ST. Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism? Br J Rheumatol. 1991. 30:301–4.
6). Tagoe C., Shah A., Yee H., Belmont HM. Aplastic anemia in systemic lupus erythematosus: a distinct presentation of acquired aplastic anemia? J Clin Rheumatol. 2001. 7:377–83.
7). Pavithran K., Raji NL., Thomas M. Aplastic anemia complicating systemic lupus erythematosus–report of a case and review of the literature. Rheumatol Int. 2002. 22:253–5.
8). Singh NP., Prakash A., Garg D., Makhija A., Pathania A., Prakash N, et al. Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine. Rheumatol Int. 2004. 24:40–2.
9). Young NS. Aplastic anemia, myelodysplasia, and related bone marrow failure syndromes. In:. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. eds.Harrison's principles of internal medicine. 16th ed.p. 617–26. New York, McGrawHill;2004.
10). Young NS. Acquired aplastic anemia. Ann Intern Med. 2002. 136:534–46.
11). Fairhurst AM., Wandstrat AE., Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol. 2006. 92:1–69.
12). Zeng W., Maciejewski JP., Chen G., Young NS. Limited heterogeneity of T cell receptor BV usage in aplastic anemia. J Clin Invest. 2001. 108:765–73.
13). Marques JA., Rhim H., Distenfeld A. Inhibition of hematopoiesis by a plasma factor in a case of aplastic anemia associated with systemic lupus erythematosus. P R Health Sci J. 1995. 14:293–6.
14). Sumimoto S., Kawai M., Kasajima Y., Hamamoto T. Aplastic anemia associated with systemic lupus erythematosus. Am J Hematol. 1991. 38:329–31.
15). 박지원: 최소연: 김현수: 남동기: 김효철: 김희연등. 재생불량성빈혈과신증후군이동반된전신성홍반성낭창환자에서plasma filtration과synchronized cyclophosphamide료1예. 대한내과학회지. 1999. 56:129–33.
16). Stricker RB., Shuman MA. Aplastic anemia complicating systemic lupus erythematosus: response to androgens in two patients. Am J Hematol. 1984. 17:193–201.
Fig. 1.
The bone marrow biopsy (H&E stain, x 100). The specimen shows marked hypocelluar marrow (cellualarity < 10%).
Table 1.
The laboratory findings of patients during follow up
XML Download